Mohini Health approves Rs 12 crore Alpine Developers deal
Key highlights
- Mohini Health approved a proposed Rs 12 crore cash acquisition of Alpine on November 14, 2026.
- Dhananya Capital is set to hold 99% of Alpine, while its director Mr. Vipan Kumar is set to hold 1%.
- Alpine reported nil turnover in each year ended March 31, 2024, March 31, 2025 and March 31, 2026.
- Alpine reported a Rs 2.05 lakh loss for financial year 2025-26 and net worth of Rs 63.62 lakh at March 31, 2026.
powered by IRIS

Mohini Health & Hygiene Limited approved a proposed Rs 12 crore cash acquisition of Alpine Developers and Promotors on November 14, 2026, through subsidiary Dhananya Capital Private Limited, which is set to hold 99% under the disclosed arrangement. Alpine reported nil turnover in every disclosed year through March 31, 2026.
Know Mohini Health & Hygiene inside out
Results, valuation, peers and who's buying, in one view.
What has Mohini Health approved?
Mohini Health approved Dhananya Capital’s proposed investment or acquisition of Alpine, a partnership firm, at its November 14, 2026 board meeting. The approval is subject to necessary formalities and applicable statutory and regulatory compliances, meaning the filing records a proposed transaction rather than a completed acquisition.
The consideration is Rs 12 crore in cash, rather than a share swap or another stated form of payment. The board meeting began at 3:30 p.m. and concluded at 5:15 p.m. on November 14, 2026, when Mohini Health also approved its unaudited standalone and consolidated financial results for the half year ended September 30, 2026.
Mohini Health made the disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement does not state a definitive agreement date, payment schedule, instalment structure or method used to determine the Rs 12 crore consideration.
What does Alpine Developers and Promotors do?
Alpine is a Punjab-based partnership firm engaged in real estate development and related activities. The filing gives May 15, 2024 as its incorporation date and identifies India as the country where it has a presence.
Alpine reported nil turnover for the years ended March 31, 2024, March 31, 2025 and March 31, 2026. The three disclosed periods therefore show no reported revenue, while the proposed transaction carries a Rs 12 crore cash consideration.
For financial year 2025-26, Alpine reported a loss after tax of Rs 2.05 lakh and net worth of Rs 63.62 lakh as at March 31, 2026. The disclosure does not provide an asset list, debt position, land holdings, project pipeline, customer contracts or valuation methodology for Alpine.
Who will hold control of Alpine after the deal?
Dhananya Capital is to hold 99% under the disclosed arrangement, while Mr. Vipan Kumar, a director of Dhananya Capital, is to hold the remaining 1%. Mohini Health presents this split in the disclosure field covering shareholding or control acquired, although Alpine is described as a partnership firm.
Mohini Health said the proposed acquisition is not a related-party transaction. It also said that none of its promoters, promoter group or group companies has an interest in the transaction announced on November 14, 2026.
Mohini Health stated that no governmental or regulatory approval is required for the acquisition. However, it gave the completion period as after completion of all regulatory compliances, rather than setting a calendar closing date.
Got a follow-up? Ask IRIS
Why is Mohini Health acquiring a real estate business?
Mohini Health said the acquisition is intended to let it explore new business opportunities, diversify revenue streams and create additional avenues for long-term growth and shareholder value creation. Management also said the transaction is expected to strengthen operations and provide opportunities to leverage potential synergies and emerging opportunities in the real estate sector.
The target’s disclosed activity is real estate development and related work, whereas Mohini Health’s standalone financial statement for the half year ended September 30, 2026 reported Rs 87.76 crore of cost of materials consumed and Rs 4.24 crore of direct manufacturing cost. Those reported cost categories provide the filing’s financial context for acquiring a real estate partnership through Dhananya Capital.
Mohini Health reported standalone revenue from operations of Rs 110.43 crore for the half year ended September 30, 2026 and profit after tax of Rs 5.66 crore for that period. These company figures do not represent guidance or a forecast of Alpine’s future revenue, profit or contribution following completion.
What else did Mohini Health’s board decide?
Mohini Health’s board approved the internal audit report and unaudited standalone and consolidated financial results for the half year ended September 30, 2026. The statutory auditor’s limited review report dated November 14, 2026 said nothing had come to its attention that caused it to believe the standalone results failed to make required disclosures or contained a material misstatement.
The board also deferred a proposed rights issue and said it would consider the fundraising proposal at a subsequent board meeting. Mohini Health said it would inform the exchange in due course, and the November 14, 2026 filing does not link any future rights-issue proceeds to the Rs 12 crore cash acquisition.
Conclusion
Mohini Health has approved a Rs 12 crore cash move into Alpine through Dhananya Capital, which is set to hold 99% while Mr. Vipan Kumar holds 1%. The target reported nil turnover in all three disclosed years through March 31, 2026, a Rs 2.05 lakh loss for financial year 2025-26 and net worth of Rs 63.62 lakh at that date.
The next disclosed acquisition milestone is completion after applicable regulatory compliances, with no fixed closing date provided. Investors can also watch for a later board meeting on the deferred rights issue, which Mohini Health said it would disclose to the exchange when reconsidered.


